CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

Those hot flashes, called vasomotor symptoms ... If you’re looking for a non-hormonal treatment, speak with your doctor to see if Veozah is right for you. Moreno advises women to undergo health ...

While not quite as effective as the standard treatment ... hormonal therapy, such as breast cancer survivors. The pills will be marketed as Veozah to treat moderate to severe hot flashes ...

The drug, deemed elinzanetant, can help reduced hot flashes and improve sleep for ... milestone in our efforts to offer a new non-hormonal option for women. This further underscores our position ...

But in mid-May, the Food and Drug Administration (FDA) approved the non-hormonal drug Fezolinetant, under the brand name Veozah, for the treatment of hot flashes and night sweats. The drug was ...

Smoking, pregnancy, and having an over- or under-active thyroid may trigger a hot flash. Read on to learn about more causes, as well as treatments ... including hormonal changes, stress and ...

Hot flashes can be debilitating and difficult ... The bottom line: "With the discovery of non-hormonal treatment options targeting the neurons responsible for VMS, menopause care should advance ...

due to rare but serious liver risks Regular liver testing is recommended during Veozah treatment to ensure early detection of potential issues Veozah was the first non-hormonal hot flash drug ...